HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jürgen Rehage Selected Research

Jürgen Rehage Research Topics

Disease

5Insulin Resistance
01/2018 - 01/2014
2Acute-Phase Reaction
01/2021 - 01/2016
2Body Weight (Weight, Body)
01/2021 - 01/2015
1Babesiosis (Piroplasmosis)
11/2020
1Necrosis
11/2020
1Hyperplasia
11/2020
1Persistent Infection
01/2019
1Infections
01/2019
1Hyperlipidemias (Hyperlipidemia)
01/2015
1Ketosis
01/2015
1Hyperinsulinism (Hyperinsulinemia)
03/2014
1Lipidoses
07/2010
1Fusariosis
08/2008

Drug/Important Bio-Agent (IBA)

3Nonesterified Fatty Acids (NEFA)IBA
01/2016 - 08/2014
3Glucose (Dextrose)FDA LinkGeneric
01/2015 - 01/2014
2MycotoxinsIBA
01/2018 - 08/2008
2Fatty Acids (Saturated Fatty Acids)IBA
01/2016 - 01/2015
2Triglycerides (Triacylglycerol)IBA
01/2015 - 07/2010
1LipopolysaccharidesIBA
01/2021
1Carnitine (L-Carnitine)FDA LinkGeneric
01/2021
1Formaldehyde (Formol)FDA Link
11/2020
1IronIBA
11/2020
1ParaffinIBA
11/2020
1RNA (Ribonucleic Acid)IBA
01/2019
1Viral RNAIBA
01/2019
1HaptoglobinsIBA
01/2016
1Niacin (Nicotinic Acid)FDA LinkGeneric
01/2016
1Ketone BodiesIBA
01/2015
1LipidsIBA
01/2015
1Biomarkers (Surrogate Marker)IBA
01/2015
1Insulin (Novolin)FDA Link
08/2014
1Conjugated Linoleic AcidsIBA
03/2014
1LactoseFDA LinkGeneric
01/2014

Therapy/Procedure

2Intravenous Injections
01/2021 - 01/2015
1Injections
01/2015
1Aftercare (After-Treatment)
01/2015